Plain-English translation of NCT06232668 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why some pregnant women develop preeclampsia—a serious condition that affects blood pressure and organs late in pregnancy. By studying tissue and blood samples collected early in pregnancy (weeks 9–15), they hope to identify warning signs that could help predict who will develop this condition before symptoms appear.
Preeclampsia can be dangerous for both mother and baby, but doctors currently have limited ways to predict who will develop it early enough to prevent problems. This study aims to find molecular markers—like fingerprints of disease—that could identify at-risk women long before symptoms show up.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll have samples collected during your already-scheduled chorionic villus biopsy (tissue sample) and a blood draw—no extra visits needed for that part. Researchers will then follow your pregnancy through delivery to see if you develop preeclampsia or other complications. The study team will track how your early-pregnancy molecular profile relates to what happens later in your pregnancy, with visits and monitoring happening as part of your normal prenatal care.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Spain